COMP <GO>
ILMN vs UNH // NET PROFIT MARGIN
Illumina Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: ILMN 6
— UNH 9
▲ NET PROFIT MARGIN LEADER: ILMN
LAST: $235.99 (-18.64%) • MKT CAP: $43.80B
net-margins
19.60%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
net-margins
3.14%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ILMN VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ILMN | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.10% | 88.57% | -22.47 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.20% | 11.47% | +6.73 | ILMN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 47.5x | 16.4x | +31.05 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 2.13% | 6.48% | -4.35 | UNH | /fcf-yield <GO> |
| Operating Margin | 18.60% | 4.82% | +13.78 | ILMN | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 19.60% | 3.14% | +16.46 | ILMN | /net-margins <GO> |
| Revenue Growth (YoY) | -0.70% | 6.46% | -7.16 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.52 | 3.12 | +6.40 | ILMN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ILMN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.74% | +0.66 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.6 | 56.0 | -17.47 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | 0.33 | +0.83 | ILMN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 47.9x | 17.1x | +30.81 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $43.80B | $364.66B | -$320.86B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ILMN REV | UNH REV | ILMN GROSS % | UNH GROSS % | ILMN FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.34B | $447.57B | 66.1% | 88.7% | $931.0M | $16.07B |
| FY 2024 | $4.37B | $400.28B | 65.4% | 88.3% | $709.0M | $20.70B |
| FY 2023 | $4.50B | $371.62B | 44.0% | 89.6% | $275.3M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ILMN // BETA 1.16
UNH // BETA 0.33